Literature DB >> 10888651

The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells.

E A Murphy1, D N Streblow, J A Nelson, M F Stinski.   

Abstract

Human cytomegalovirus (HCMV) infection of permissive cells has been reported to induce a cell cycle halt. One or more viral proteins may be involved in halting progression at different stages of the cell cycle. We investigated how HCMV infection, and specifically IE86 protein expression, affects the cell cycles of permissive and nonpermissive cells. We used a recombinant virus that expresses the green fluorescent protein (GFP) to determine the effects of HCMV on the cell cycle of permissive cells. Fluorescence by GFP allowed us to select for only productively infected cells. Replication-defective adenovirus vectors expressing the IE72 or IE86 protein were also used to efficiently transduce 95% or more of the cells. The adenovirus-expressed IE86 protein was determined to be functional by demonstrating negative autoregulation of the major immediate-early promoter and activation of an early viral promoter in the context of the viral genome. To eliminate adenovirus protein effects, plasmids expressing GFP for fluorescent selection of only transfected cells and wild-type IE86 protein or a mutant IE86 protein were tested in permissive and nonpermissive cells. HCMV infection induced the entry of U373 cells into the S phase. All permissive cells infected with HCMV were blocked in cell cycle progression and could not divide. After either transduction or transfection and IE86 protein expression, the number of all permissive or nonpermissive cell types in the S phase increased significantly, but the cells could no longer divide. The IE72 protein did not have a significant effect on the S phase. Since IE86 protein inhibits cell cycle progression, the IE2 gene in a human fibroblast IE86 protein-expressing cell line was sequenced. The IE86 protein in these retrovirus-transduced cells has mutations in a critical region of the viral protein. The locations of the mutations and the function of the IE86 protein in controlling cell cycle progression are discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888651      PMCID: PMC112229          DOI: 10.1128/jvi.74.15.7108-7118.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters.

Authors:  M J Tevethia; D J Spector; K M Leisure; M F Stinski
Journal:  Virology       Date:  1987-12       Impact factor: 3.616

2.  The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin.

Authors:  L A Samaniego; M J Tevethia; D J Spector
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

3.  Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter.

Authors:  T W Hermiston; C L Malone; P R Witte; M F Stinski
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

4.  Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex.

Authors:  D M Lukac; J R Manuppello; J C Alwine
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain.

Authors:  R Jupp; S Hoffmann; R M Stenberg; J A Nelson; P Ghazal
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  Identification and mapping of dimerization and DNA-binding domains in the C terminus of the IE2 regulatory protein of human cytomegalovirus.

Authors:  C J Chiou; J Zong; I Waheed; G S Hayward
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

7.  E2F mediates dihydrofolate reductase promoter activation and multiprotein complex formation in human cytomegalovirus infection.

Authors:  M Wade; T F Kowalik; M Mudryj; E S Huang; J C Azizkhan
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

8.  Potential role of human cytomegalovirus and p53 interaction in coronary restenosis.

Authors:  E Speir; R Modali; E S Huang; M B Leon; F Shawl; T Finkel; S E Epstein
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

9.  Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein.

Authors:  C Hagemeier; R Caswell; G Hayhurst; J Sinclair; T Kouzarides
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

10.  The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation.

Authors:  R Caswell; C Hagemeier; C J Chiou; G Hayward; T Kouzarides; J Sinclair
Journal:  J Gen Virol       Date:  1993-12       Impact factor: 3.891

View more
  76 in total

1.  Characterization of a human cytomegalovirus with phosphorylation site mutations in the immediate-early 2 protein.

Authors:  Julie A Heider; Yongjun Yu; Thomas Shenk; James C Alwine
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Viable human cytomegalovirus recombinant virus with an internal deletion of the IE2 86 gene affects late stages of viral replication.

Authors:  Veronica Sanchez; Charles L Clark; Judy Y Yen; Roopashree Dwarakanath; Deborah H Spector
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 3.  Herpesvirus lytic replication and the cell cycle: arresting new developments.

Authors:  E K Flemington
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle.

Authors:  Robert F Kalejta; Thomas Shenk
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.

Authors:  Hiroki Isomura; Mark F Stinski
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

6.  Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis.

Authors:  A Louise McCormick; Vanessa L Smith; Dar Chow; Edward S Mocarski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response.

Authors:  Jayme Salsman; Madhav Jagannathan; Patrick Paladino; Pak-Kei Chan; Graham Dellaire; Brian Raught; Lori Frappier
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

8.  The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block.

Authors:  Amy Mauser; Elizabeth Holley-Guthrie; Dennis Simpson; William Kaufmann; Shannon Kenney
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

10.  Human cytomegalovirus UL84 localizes to the cell nucleus via a nuclear localization signal and is a component of viral replication compartments.

Authors:  Yiyang Xu; Kelly S Colletti; Gregory S Pari
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.